H60b Inhibitors
Chemical inhibitors of H60b, a ligand for the activating receptor NKG2D on natural killer (NK) and T cells, can modulate the immune response through various signaling pathways. Cyclosporin A, by inhibiting calcineurin, can decrease the production of IL-2, a key cytokine for T-cell proliferation, thus dampening the activation of T cells that would otherwise respond to H60b. Similarly, Rapamycin's binding to FKBP12 and subsequent inhibition of mTOR can suppress the proliferation and function of immune cells, leading to a reduced response to H60b. LY294002 and Wortmannin both target the PI3K pathway, which is crucial for cell survival and activation. Their inhibitory action can decrease the functional activation of NK and T cells that interact with H60b, curtailing their immune response.
Moreover, several inhibitors target the MAPK signaling pathway, which plays a significant role in cell growth and immune cell differentiation. PD98059 and U0126 specifically inhibit MEK1/2, thereby preventing the activation of the ERK pathway that is involved in the functional response to H60b. SB203580 and SP600125, inhibiting p38 MAPK and JNK respectively, can alter stress and inflammation responses, further reducing the functional response of immune cells to H60b. Dasatinib and PP2, as inhibitors of the Src family kinases, can suppress the signaling that regulates immune cell activation responding to H60b. Each of these chemical inhibitors, by targeting specific signaling cascades, can modulate the functional response of immune cells to the presence of H60b.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, which is crucial for T-cell activation. By inhibiting calcineurin, Cyclosporin A ultimately leads to a decrease in IL-2 production, a cytokine necessary for T-cell proliferation. Since H60b is a ligand for NKG2D, a receptor on NK and T cells, inhibiting T-cell activation can reduce the functional response of NKG2D and therefore inhibit H60b-mediated immune responses. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and inhibits the mammalian target of rapamycin (mTOR), a key regulator of cell growth and proliferation. This inhibition can decrease the activity of immune cells that interact with H60b, thereby reducing the functional response to H60b engagement on target cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK1, which is upstream of ERK in the MAPK signaling pathway. Since ERK can be involved in the signaling downstream of NKG2D, which interacts with H60b, inhibiting MEK1 and thus ERK activity can decrease the functional response of cells to H60b. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK. The p38 MAPK pathway is involved in stress and inflammation responses. By inhibiting p38 MAPK, SB203580 can reduce the activity of immune cells that would respond to H60b, thereby inhibiting the protein's functional effects on immune response regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which is part of the signaling pathway involved in cell growth and survival. The PI3K pathway is also implicated in the activation of NK and T cells, which interact with H60b. Inhibition of PI3K can thus reduce the functional activation of these cells and their response to H60b. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that can inhibit the Src family kinases. Src kinases are implicated in signaling pathways that regulate immune cell activation including those that involve H60b. By inhibiting Src family kinases, Dasatinib can reduce the functional activation of NK and T cells in response to H60b. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, preventing the activation of the ERK pathway. Since the ERK pathway can be involved in the signaling processes of immune cells responding to H60b, inhibition of MEK1/2 by U0126 can result in decreased functional response to H60b. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK signaling pathways involved in the regulation of apoptosis and immune response. Inhibition of JNK can therefore impair the signaling related to immune cell activation and function that would typically respond to the presence of H60b, leading to an inhibition of H60b's role in immune signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases, which are involved in signaling pathways that regulate the activation of immune cells, including their response to H60b. Inhibition of these kinases by PP2 can decrease the activation and function of cells in response to H60b. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K). By inhibiting PI3K, it leads to reduced activation of downstream signaling pathways essential for immune cell function. This inhibition can therefore impair the functional activation of immune cells, such as NK and T cells, which interact with H60b, leading to decreased responsiveness to H60b signaling. | ||||||